For citations:
Teplyakov A.T., Shilov S.N., Popova A.A., Berezikova E.N., Neupokoeva M.N., Grakova E.V., Kopeva K.V. The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy. Cardiovascular Therapy and Prevention. 2019;18(1):127-133. (In Russ.) https://doi.org/10.15829/1728-8800-2019-1-127-133